MA37659B1 - Lactam compounds for use in the preparation of a pharmaceutical composition for treating hepatitis c virus infection - Google Patents

Lactam compounds for use in the preparation of a pharmaceutical composition for treating hepatitis c virus infection

Info

Publication number
MA37659B1
MA37659B1 MA37659A MA37659A MA37659B1 MA 37659 B1 MA37659 B1 MA 37659B1 MA 37659 A MA37659 A MA 37659A MA 37659 A MA37659 A MA 37659A MA 37659 B1 MA37659 B1 MA 37659B1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical composition
virus infection
treating hepatitis
lactam compounds
Prior art date
Application number
MA37659A
Other languages
French (fr)
Other versions
MA37659A1 (en
Inventor
Kyla Bjornson
Eda Canales
Jeromy Cottell
Kapil Karki
Ashley Katana
Darryl Kato
Tetsuya Kobayashi
John Link
Ruben Martinez
Barton Phillips
Hyung-Jung Pyun
Michael Sangi
Adam Schrier
Dustin Siegel
James Taylor
Chinh Tran
Martin Teresa Trejo
Randall Vivian
Zheng-Yu Yang
Jeff Zablocki
Sheila Zipfel
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority claimed from PCT/US2013/049119 external-priority patent/WO2014008285A1/en
Publication of MA37659A1 publication Critical patent/MA37659A1/en
Publication of MA37659B1 publication Critical patent/MA37659B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés de la formule i, ainsi que des sels de qualité pharmaceutique de ceux-ci. L'invention concerne également des procédés d'utilisation desdits composés et des compositions pharmaceutiques contenant lesdits composés.The invention relates to compounds of formula I, as well as pharmaceutically acceptable salts thereof. The invention also relates to methods of using said compounds and pharmaceutical compositions containing said compounds.

MA37659A 2012-07-03 2013-07-02 Lactam compounds for use in the preparation of a pharmaceutical composition for treating hepatitis c virus infection MA37659B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261667806P 2012-07-03 2012-07-03
PCT/US2013/049119 WO2014008285A1 (en) 2012-07-03 2013-07-02 Inhibitors of hepatitis c virus

Publications (2)

Publication Number Publication Date
MA37659A1 MA37659A1 (en) 2018-01-31
MA37659B1 true MA37659B1 (en) 2018-09-28

Family

ID=61730525

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37659A MA37659B1 (en) 2012-07-03 2013-07-02 Lactam compounds for use in the preparation of a pharmaceutical composition for treating hepatitis c virus infection

Country Status (1)

Country Link
MA (1) MA37659B1 (en)

Also Published As

Publication number Publication date
MA37659A1 (en) 2018-01-31

Similar Documents

Publication Publication Date Title
UA114351C2 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MA37400B1 (en) Heterocyclyl compounds as mek inhibitors
MA34896B1 (en) INHIBITORS OF HEPATITIS C VIRUS
MA38138A1 (en) New derivatives of quinolone
MA34819B1 (en) BICYCLO [3.2.1] OCTYLAMIDE DERIVATIVES AND USES THEREOF
MA37891B1 (en) Alcoxypyrazoles as activators of soluble guanylate cyclase
MA34392B1 (en) PYRIMIDINES AS ANTIVIRAL AGENTS
MA35750B1 (en) 2 ', 4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of vhc rna replication (hepatitis c virus)
MA35184B1 (en) Antagonists of trpv4
EA201201031A1 (en) HEPATITIS C VIRUS INHIBITORS
MA35104B1 (en) Inhibitor of the hepatitis c virus
MA35576B1 (en) New compounds
MA35132B1 (en) 4-aryl-n-phenyl-1,3,5-triazine-2-amines containing a sulfoximine group
EA201490647A1 (en) DERIVATIVES OF BENZOTHIAZOL-6-LUCUS ACID AND THEIR APPLICATION FOR THE TREATMENT OF HIV INFECTION
MA37712B1 (en) Macrocyclic inhibitors of flaviviridae virus
MA35749B1 (en) Nucleoside derivatives 4'-azido, 3'-fluoro substituted as inhibitors of vhc arn replication
MA34147B1 (en) SILYL FUSIONED TRICYCLIC COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF VIRAL DISEASES
UA114726C2 (en) 1,4-DISASSEMBLY ANALYSIS OF PIDIDASINE AND METHODS OF TREATMENT OF SMN DEFICIENCES
MA37142A3 (en) Derivatives of dihydro-benzo-oxazine and dihydro-pyrido-oxazine
MX375432B (en) INHIBITORS OF THE REPLICATION OF FLU VIRUSES.
EA201400358A1 (en) SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTAN-3-CARBOXAMIDE INHIBITORS KATEPSIN C
EA028928B9 (en) 2'-substituted carba-nucleoside analogs for antiviral treatment
IN2014CN00562A (en)
MA37886A1 (en) New bicyclic pyridinones
MA35443B1 (en) Benzofuran compounds for the treatment of infections with the hepatitis c virus